EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma

Journal of Hepatology

Volumn 52, Issue 2, 2010, Pages 280-281

  Terris, Benoit ^a,b,c   Cavard, Catherine ^a,b   Perret, Christine ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

^c Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; EPITHELIAL CELL ADHESION MOLECULE; SMALL INTERFERING RNA; TUMOR MARKER; WNT PROTEIN;

ARTICLE; CANCER INVASION; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL HETEROGENEITY; CELL PROLIFERATION; DRUG TARGETING; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPHEROID CELL;

EID: 75549088882     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.10.026     Document Type: Note

References (12)

1. Visvader J.E., and Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8 (2008) 755-768
2. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 (2007) 2557-2576
3. Yamashita T., Ji J., Budhu A., Forgues M., Yang W., Wang H.Y., et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136 (2009) 1012-1024
4. Schmelzer E., Zhang L., Bruce A., Wauthier E., Ludlow J., Yao H.L., et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 204 (2007) 1973-1987
5. Tanaka M., Okabe M., Suzuki K., Kamiya Y., Tsukahara Y., Saito S., et al. Mouse hepatoblasts at distinct developmental stages are characterized by expression of EpCAM and DLK1: drastic change of EpCAM expression during liver development. Mech Dev 126 (2009) 665-676
6. Yamashita T., Forgues M., Wang W., Kim J.W., Ye Q., Jia H., et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res 68 (2008) 1451-1461
7. Yamashita T., Budhu A., Forgues M., and Wang X.W. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res 67 (2007) 10831-10839
8. Chiba T., Zheng Y.W., Kita K., Yokosuka O., Saisho H., Onodera M., et al. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation. Gastroenterology 133 (2007) 937-950
9. Audard V., Grimber G., Elie C., Radenen B., Audebourg A., Letourneur F., et al. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J Pathol 212 (2007) 345-352
10. Boyault S., Rickman D.S., de Reynies A., Balabaud C., Rebouissou S., Jeannot E., et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45 (2007) 42-52
11. Hoshida Y., Nijman S.M., Kobayashi M., Chan J.A., Brunet J.P., Chiang D.Y., et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69 (2009) 7385-7392
12. Monga S.P., Mars W.M., Pediaditakis P., Bell A., Mule K., Bowen W.C., et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res 62 (2002) 2064-2071